Report Detail
Global Endometriosis Treatment Market Insights, Forecast to 2025
- RnM3447587 |
- 22 May, 2019 |
- Global |
- 117 Pages |
- QYResearch |
- Pharma & Healthcare
Therapies used to treat endometriosis include: Hormonal contraceptives. Birth control pills, patches and vaginal rings help control the hormones responsible for the buildup of endometrialtissue each month
The global Endometriosis Treatment market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Endometriosis Treatment market based on company, product type, end user and key regions.
This report studies the global market size of Endometriosis Treatment in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Endometriosis Treatment in these regions.
This research report categorizes the global Endometriosis Treatment market by top players/brands, region, type and end user. This report also studies the global Endometriosis Treatment market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
AbbVie
Eli Lilly
AstraZeneca
Bayer
Astellas Pharma
Meditrina Pharmaceuticals
Pfizer
Neurocrine Biosciences
Takeda Pharmaceutical
Market size by Product
Hormonal Contraceptives
Gonadotropin-releasing Hormone (Gn-RH) Agonists
Progestin Therapy
Aromatase Inhibitors
Market size by End User
Hospital
Clinic
Other
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Endometriosis Treatment market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Endometriosis Treatment market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Endometriosis Treatment companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Endometriosis Treatment submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Endometriosis Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Endometriosis Treatment market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Endometriosis Treatment Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Endometriosis Treatment Market Size Growth Rate by Product
- 1.4.2 Hormonal Contraceptives
- 1.4.3 Gonadotropin-releasing Hormone (Gn-RH) Agonists
- 1.4.4 Progestin Therapy
- 1.4.5 Aromatase Inhibitors
- 1.5 Market by End User
- 1.5.1 Global Endometriosis Treatment Market Size Growth Rate by End User
- 1.5.2 Hospital
- 1.5.3 Clinic
- 1.5.4 Other
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Endometriosis Treatment Market Size
- 2.1.1 Global Endometriosis Treatment Revenue 2014-2025
- 2.1.2 Global Endometriosis Treatment Sales 2014-2025
- 2.2 Endometriosis Treatment Growth Rate by Regions
- 2.2.1 Global Endometriosis Treatment Sales by Regions
- 2.2.2 Global Endometriosis Treatment Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Endometriosis Treatment Sales by Manufacturers
- 3.1.1 Endometriosis Treatment Sales by Manufacturers
- 3.1.2 Endometriosis Treatment Sales Market Share by Manufacturers
- 3.1.3 Global Endometriosis Treatment Market Concentration Ratio (CR5 and HHI)
- 3.2 Endometriosis Treatment Revenue by Manufacturers
- 3.2.1 Endometriosis Treatment Revenue by Manufacturers (2014-2019)
- 3.2.2 Endometriosis Treatment Revenue Share by Manufacturers (2014-2019)
- 3.3 Endometriosis Treatment Price by Manufacturers
- 3.4 Endometriosis Treatment Manufacturing Base Distribution, Product Types
- 3.4.1 Endometriosis Treatment Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Endometriosis Treatment Product Type
- 3.4.3 Date of International Manufacturers Enter into Endometriosis Treatment Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Endometriosis Treatment Sales by Product
- 4.2 Global Endometriosis Treatment Revenue by Product
- 4.3 Endometriosis Treatment Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Endometriosis Treatment Breakdown Data by End User
6 North America
- 6.1 North America Endometriosis Treatment by Countries
- 6.1.1 North America Endometriosis Treatment Sales by Countries
- 6.1.2 North America Endometriosis Treatment Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Endometriosis Treatment by Product
- 6.3 North America Endometriosis Treatment by End User
7 Europe
- 7.1 Europe Endometriosis Treatment by Countries
- 7.1.1 Europe Endometriosis Treatment Sales by Countries
- 7.1.2 Europe Endometriosis Treatment Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Endometriosis Treatment by Product
- 7.3 Europe Endometriosis Treatment by End User
8 Asia Pacific
- 8.1 Asia Pacific Endometriosis Treatment by Countries
- 8.1.1 Asia Pacific Endometriosis Treatment Sales by Countries
- 8.1.2 Asia Pacific Endometriosis Treatment Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Endometriosis Treatment by Product
- 8.3 Asia Pacific Endometriosis Treatment by End User
9 Central & South America
- 9.1 Central & South America Endometriosis Treatment by Countries
- 9.1.1 Central & South America Endometriosis Treatment Sales by Countries
- 9.1.2 Central & South America Endometriosis Treatment Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Endometriosis Treatment by Product
- 9.3 Central & South America Endometriosis Treatment by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Endometriosis Treatment by Countries
- 10.1.1 Middle East and Africa Endometriosis Treatment Sales by Countries
- 10.1.2 Middle East and Africa Endometriosis Treatment Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Endometriosis Treatment by Product
- 10.3 Middle East and Africa Endometriosis Treatment by End User
11 Company Profiles
- 11.1 AbbVie
- 11.1.1 AbbVie Company Details
- 11.1.2 Company Business Overview
- 11.1.3 AbbVie Endometriosis Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 AbbVie Endometriosis Treatment Products Offered
- 11.1.5 AbbVie Recent Development
- 11.2 Eli Lilly
- 11.2.1 Eli Lilly Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Eli Lilly Endometriosis Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Eli Lilly Endometriosis Treatment Products Offered
- 11.2.5 Eli Lilly Recent Development
- 11.3 AstraZeneca
- 11.3.1 AstraZeneca Company Details
- 11.3.2 Company Business Overview
- 11.3.3 AstraZeneca Endometriosis Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 AstraZeneca Endometriosis Treatment Products Offered
- 11.3.5 AstraZeneca Recent Development
- 11.4 Bayer
- 11.4.1 Bayer Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Bayer Endometriosis Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Bayer Endometriosis Treatment Products Offered
- 11.4.5 Bayer Recent Development
- 11.5 Astellas Pharma
- 11.5.1 Astellas Pharma Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Astellas Pharma Endometriosis Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Astellas Pharma Endometriosis Treatment Products Offered
- 11.5.5 Astellas Pharma Recent Development
- 11.6 Meditrina Pharmaceuticals
- 11.6.1 Meditrina Pharmaceuticals Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Meditrina Pharmaceuticals Endometriosis Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Meditrina Pharmaceuticals Endometriosis Treatment Products Offered
- 11.6.5 Meditrina Pharmaceuticals Recent Development
- 11.7 Pfizer
- 11.7.1 Pfizer Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Pfizer Endometriosis Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Pfizer Endometriosis Treatment Products Offered
- 11.7.5 Pfizer Recent Development
- 11.8 Neurocrine Biosciences
- 11.8.1 Neurocrine Biosciences Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Neurocrine Biosciences Endometriosis Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Neurocrine Biosciences Endometriosis Treatment Products Offered
- 11.8.5 Neurocrine Biosciences Recent Development
- 11.9 Takeda Pharmaceutical
- 11.9.1 Takeda Pharmaceutical Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Takeda Pharmaceutical Endometriosis Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Takeda Pharmaceutical Endometriosis Treatment Products Offered
- 11.9.5 Takeda Pharmaceutical Recent Development
12 Future Forecast
- 12.1 Endometriosis Treatment Market Forecast by Regions
- 12.1.1 Global Endometriosis Treatment Sales Forecast by Regions 2019-2025
- 12.1.2 Global Endometriosis Treatment Revenue Forecast by Regions 2019-2025
- 12.2 Endometriosis Treatment Market Forecast by Product
- 12.2.1 Global Endometriosis Treatment Sales Forecast by Product 2019-2025
- 12.2.2 Global Endometriosis Treatment Revenue Forecast by Product 2019-2025
- 12.3 Endometriosis Treatment Market Forecast by End User
- 12.4 North America Endometriosis Treatment Forecast
- 12.5 Europe Endometriosis Treatment Forecast
- 12.6 Asia Pacific Endometriosis Treatment Forecast
- 12.7 Central & South America Endometriosis Treatment Forecast
- 12.8 Middle East and Africa Endometriosis Treatment Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Endometriosis Treatment Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Endometriosis Treatment . Industry analysis & Market Report on Endometriosis Treatment is a syndicated market report, published as Global Endometriosis Treatment Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Endometriosis Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
